Program Manager, Viral Hepatitis Center
Division of Infectious Disease
Department of Medicine
Johns Hopkins University School of Medicine
Associate Professor of Medicine
University of Toronto
Toronto Centre for Liver Disease
Sandra Rotman Centre for Global Health
The Kirby Institute, UNSW Australia
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center
Clinical Pharmacy Specialist for Hepatology
Rush Specialty Pharmacy
This program has been made available online.
Latest data from a multicenter cohort study of HCC recurrence in patients receiving HCV DAA therapy following HCC CR at AASLD 2018 reported by Clinical Care Options
Expert commentary from Dr. Mark Sulkowski on strategies to achieve HCV elimination in persons living with HIV
Susanna Naggie, MD, MHS, on HCV and HIV coinfection FAQs and challenges. Guideline-based strategies, common DAA and ART drug interactions (DDIs).
Tool, education to avoid drug interactions, follow guidelines when choosing anti-HCV DAA and anti-HIV ART drugs for patients with HCV/HIV coinfection.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.